This trial is using different chemotherapy regimens for low, intermediate, and high risk classical Hodgkin lymphoma patients. Two cycles of therapy will be given, and if there is no adequate response, radiotherapy will be given.
1 Primary · 5 Secondary · Reporting Duration: after the first 2 cycles of chemotherapy (at approximately 2 months after enrollment
Experimental Treatment
250 Total Participants · 3 Treatment Groups
Primary Treatment: Radiotherapy · No Placebo Group · Phase 2
Age < 65 · All Participants · 10 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: